Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes and cancer with “precision medicine”. Leverage the power of TipRanks ...

SelectQuote (SLQT) announced that the company signed a $350M strategic investment from funds managed by Bain Capital, Morgan Stanley Private Credit, and Newlight Partners. The transaction ...

In the midst of all the cloak and dagger secrecy surrounding the potential sale of the Boston Celtics, lost in the shuffle of ...

Apleona is a European provider of integrated facility management. Bain Capital has acquired Apleona from PAI Partners.

Jan 28 (Reuters) - Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners (SGRY.O), opens new tab it does not already own for $25. ...

Bain Capital, the Boston-based private equity firm, is reportedly nearing the acquisition of Apleona Group GmbH, a German ...

Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment ...

“Milacron is an iconic American manufacturing business with a 50-year legacy of driving innovation in plastics,” said Matt Evans, a partner at Bain Capital Special Situations in a statement.

Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Founded in 1678 ...

Insignia's shares peak to a 3-year high Due diligence to Bain, CC Capital granted Bain matches CC Capitals' A$4.43 apiece offer Jan 23 (Reuters) - Insignia Financial's (IFL.AX), opens new tab ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...